The effects of potent topical corticosteroids on adrenocortical function.
D000284:Administration, Oral; D000287:Administration, Topical; D000302:Adrenal Cortex / Q000187:drug effects* / Q000378:metabolism; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives; D019819:Budesonide; D002990:Clobetasol / Q000008:administration & dosage / Q000031:analogs & derivatives; D004060:Diflucortolone / Q000008:administration & dosage / Q000031:analogs & derivatives; D004305:Dose-Response Relationship, Drug; D004485:Eczema / Q000097:blood*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011282:Pregnenediones / Q000008:administration & dosage; D011565:Psoriasis / Q000097:blood*
D000893:Anti-Inflammatory Agents; D009824:Ointments; D011282:Pregnenediones; C013486:diflucortolone valerate; D019819:Budesonide; D001623:Betamethasone; D002990:Clobetasol; D004060:Diflucortolone; C014477:diflorasone; D006854:Hydrocortisone